Blog
RSS FeedPosted by Michael Wonder on 17 Nov 2016
FDA research to help speed development of Zika virus vaccines and therapeutics
17 November 2016 - Neonatal mouse model provides a new platform for Zika virus research. ...
Posted by Michael Wonder on 17 Nov 2016
FDA approves Intrarosa for postmenopausal women experiencing pain during sex
17 November 2016 - The U.S. FDA approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse ...
Posted by Michael Wonder on 17 Nov 2016
The end of Obamacare
17 November 2016 - Donald Trump’s triumph in the 2016 presidential election marks the beginning of an uncertain and tumultuous chapter ...
Posted by Michael Wonder on 17 Nov 2016
Maintaining insurance access under Trump — a strategy
16 November 2016 - Donald Trump’s election as President puts the future of the Affordable Care Act (ACA) in jeopardy. ...
Posted by Michael Wonder on 17 Nov 2016
Centrexion Therapeutics announces fast track designation granted by FDA to CNTX-4975 for treatment of Morton’s neuroma
15 November 2016 - CNTX-4975 has potential to be the first non-surgical FDA-approved treatment for orphan disease, painful foot nerve ...
Posted by Michael Wonder on 16 Nov 2016
Amgen and Allergan submit biosimilar biologics license application for ABP 215 to U.S. FDA
15 November 2016 - Supported by phase 3 study in patients with non-squamous non-small-cell lung cancer. ...
Posted by Michael Wonder on 16 Nov 2016
Drug makers to FDA: Let us share off-label study data with payers
16 November 2016 - Now that pharma has prevailed in free-speech legal battles concerning off-label marketing, it’s pushing the FDA ...
Posted by Michael Wonder on 16 Nov 2016
How drug price pressure helped sink Novo's insulin pill
16 November 2016 - Commercial rather than technical hurdles ultimately torpedoed Novo Nordisk's bid to make an oral form of ...
Posted by Michael Wonder on 16 Nov 2016
How to make drug prices fair to U.S. consumers
16 November 2016 - Americans pay far more for branded prescription drugs than people in any other developed nation, exactly ...
Posted by Michael Wonder on 16 Nov 2016
Trump used to rail against drug prices. Now the industry's allies are helping shape his agenda
15 November 2016 - President-elect Donald Trump made the cost of prescription drugs a central part of his healthcare pitch while ...
Posted by Michael Wonder on 16 Nov 2016
Trump should be good medicine for the pharmaceutical industry. Here’s why
15 November 2016 - The holidays came early for the pharmaceutical industry this year. ...
Posted by Michael Wonder on 16 Nov 2016
AMA embraces value-based drug pricing
15 November 2016 - The US' largest physician organisation is supporting value-based pricing for medications. ...
Posted by Michael Wonder on 16 Nov 2016
Study shows promise for expensive cholesterol drugs, but they are still hard to obtain
15 November 2016 - If there is one thing decades of studies with tens of thousands of heart disease patients ...
Posted by Michael Wonder on 16 Nov 2016
Republican lawmakers are scrambling to find an alternative to Obamacare
16 November 2016 - Congress is poised to repeal the Affordable Care Act. What might replace it? ...
Posted by Michael Wonder on 16 Nov 2016
ARMO BioSciences’ immunotherapy AM0010 receives orphan drug and fast track designations from the U.S. FDA for the treatment of pancreatic cancer
14 November 2016 - ARMO BioSciences announced that the U.S. FDA has granted the Company’s lead investigational immuno-oncology drug AM0010 ...